Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.00% is 100% above its 5-year average of -558.31%, near the high end of its 5-year range (-2248.84%–653.97%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% above its 12-month average of -659.11%.
Reported quarterly operating margin; no daily interpolation. Q1 FY2027 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
-659.11%
OPERATING MARGIN AVG 3Y
-705.07%
OPERATING MARGIN AVG 5Y
-558.31%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+100.00%
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Valion Bio, Inc.
Market Cap
$9.86M
Operating Margin
0.00%
TTM Avg
-659.11%
3Y Avg
-705.07%
5Y Avg
-558.31%
Market Cap
$9.83M
Operating Margin
-34.94%
TTM Avg
-189.60%
3Y Avg
-1712.92%
5Y Avg
-2140.33%
Market Cap
$9.71M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$10.06M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$10.06M
Operating Margin
-289668.18%
TTM Avg
-144834.09%
3Y Avg
-74061.36%
5Y Avg
-50713.07%
Market Cap
$10.13M
Operating Margin
0.00%
TTM Avg
-390.79%
3Y Avg
-392.52%
5Y Avg
-325.49%
Market Cap
$9.50M
Operating Margin
-11268.32%
TTM Avg
-39020.24%
3Y Avg
-22313.14%
5Y Avg
-16433.29%
Market Cap
$10.21M
Operating Margin
-76.66%
TTM Avg
-76.42%
3Y Avg
-167.47%
5Y Avg
-192.55%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Valion Bio, Inc. (VBIO) | $9.86M | 0.00% | -659.11% | -705.07% | -558.31% |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.83M | -34.94% | -189.60% | -1712.92% | -2140.33% |
| MetaVia Inc. (MTVA)vs › | $9.75M | 0.00% | 0.00% | 0.00% | 0.00% |
| Satellos Bioscience Inc. (MSLE)vs › | $9.71M | 0.00% | 0.00% | 0.00% | 0.00% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| Senti Biosciences, Inc. (SNTI)vs › | $10.06M | -289668.18% | -144834.09% | -74061.36% | -50713.07% |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.13M | 0.00% | -390.79% | -392.52% | -325.49% |
| Ainos, Inc. (AIMD)vs › | $9.50M | -11268.32% | -39020.24% | -22313.14% | -16433.29% |
| Lifeward Ltd. (LFWD)vs › | $10.21M | -76.66% | -76.42% | -167.47% | -192.55% |
| Adial Pharmaceuticals, Inc. (ADIL)vs › | $10.45M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 653.97% |
| 2025-09-30 | -1700.68% |
| 2025-06-30 | -2248.84% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | -857.22% |
| 2024-09-30 | -1135.71% |
| 2024-06-30 | -861.43% |
| 2024-03-31 | -443.41% |
| 2023-12-31 | -628.57% |
| 2023-09-30 | -624.11% |
| 2023-06-30 | -1319.88% |
| 2023-03-31 | -562.77% |
| 2022-12-31 | -552.94% |
| 2022-09-30 | -541.72% |
| 2022-06-30 | -571.59% |
| 2022-03-31 | -523.60% |
| 2021-12-31 | -589.20% |
| 2021-09-30 | -443.68% |
| 2021-06-30 | -393.66% |
| 2021-03-31 | -327.24% |
| 2020-12-31 | -216.98% |
| 2020-09-30 | -334.98% |
| 2020-06-30 | -466.94% |
| 2020-03-31 | -824.59% |
